BioSig Technologies Delays Quarterly Report Filing

BioSig Technologies ( (BSGM) ) has released a notification of late filing.

BioSig Technologies, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The delay is primarily due to time constraints in compiling, disseminating, and reviewing the necessary financial information, which made timely filing impractical without undue hardship and expense. The company expects to file the report no later than the fifth calendar day following the prescribed due date. Financially, BioSig Technologies anticipates significant changes in its results, with a notable increase in general and administrative expenses and a substantial rise in loss from operations compared to the previous year. The company assures that while these preliminary figures are subject to change, they do not expect material alterations. BioSig Technologies is committed to ongoing compliance, as indicated by the signature of Ferdinand Groenewald, Interim Chief Financial Officer, on the notification.

The most recent analyst rating on (BSGM) stock is a Buy with a $2.75 price target. To see the full list of analyst forecasts on BioSig Technologies stock, see the BSGM Stock Forecast page.

Spark’s Take on BSGM Stock

According to Spark, TipRanks’ AI Analyst, BSGM is a Underperform.

BioSig Technologies faces significant financial difficulties, with persistent losses, high leverage, and negative cash flow trends. While technical analysis indicates some short-term momentum, potential overbought conditions warrant caution. The negative P/E ratio further underscores valuation challenges and risks associated with the stock.

To see Spark’s full report on BSGM stock, click here.

More about BioSig Technologies

Average Trading Volume: 1,174,511

Technical Sentiment Signal: Buy

Current Market Cap: $159.8M

See more data about BSGM stock on TipRanks’ Stock Analysis page.